Royalty Pharma

33.28
0.69 (2.12%)
At close: Feb 20, 2025, 3:59 PM
33.50
0.66%
After-hours: Feb 20, 2025, 04:38 PM EST

Royalty Pharma Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for RPRX stock have an median target of 40, with a low estimate of 28 and a high estimate of 51. The median target predicts an increase of 20.19% from the current stock price of 33.28.

Analyst Consensus: Buy
Target Low Average Median High
Price $28 $41.6 $40 $51
Change -15.87% 25.00% 20.19% 53.25%

AI Analyst Report

According to 5 stock analyst, the rating for Royalty Pharma is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Apr 24Jun 24Jul 24Aug 24Oct 24
Strong Buy 00010
Buy 10101
Hold 01000
Sell 00000
Strong Sell 00000
Total 1 1 1 1 1

Financial Forecast this Year

Revenue This Year
3.04B
from 2.26B
Increased by 34.2%
Revenue Next Year
3.19B
from 3.04B
Increased by 5.0%
EPS This Year
4.66
from 1.92
Increased by 142.7%
EPS Next Year
5
from 4.66
Increased by 7.3%